4.7 Article

CASowary: CRISPR-Cas13 guide RNA predictor for transcript depletion

Journal

BMC GENOMICS
Volume 23, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12864-022-08366-2

Keywords

CRISPR; Cas13; mRNA regulation; Gene editing; Functional genomics; Machine learning; Protein expression

Funding

  1. National Institute of General Medical Sciences of the National Institutes of Health [R01GM123314]
  2. Eli Lilly Research Award Program grant
  3. National Institute of General Medical Sciences of the National Institutes of Health (NIH) [R35 GM119840]
  4. National Institute of Mental Health of the National Institutes of Health (NIH) [R01 MH122142]

Ask authors/readers for more resources

CASowary is a novel machine learning and computational tool to predict the efficacy of sgRNAs, providing high-quality guide predictions for numerous transcripts in a cell line-specific manner. Application of this tool should facilitate rapid deployment of CRISPR/Cas13 systems, aiding in the development of therapeutic interventions linked with aberrations in RNA regulatory processes.
Background Recent discovery of the gene editing system - CRISPR (Clustered Regularly Interspersed Short Palindromic Repeats) associated proteins (Cas), has resulted in its widespread use for improved understanding of a variety of biological systems. Cas13, a lesser studied Cas protein, has been repurposed to allow for efficient and precise editing of RNA molecules. The Cas13 system utilizes base complementarity between a crRNA/sgRNA (crispr RNA or single guide RNA) and a target RNA transcript, to preferentially bind to only the target transcript. Unlike targeting the upstream regulatory regions of protein coding genes on the genome, the transcriptome is significantly more redundant, leading to many transcripts having wide stretches of identical nucleotide sequences. Transcripts also exhibit complex three-dimensional structures and interact with an array of RBPs (RNA Binding Proteins), both of which may impact the effectiveness of transcript depletion of target sequences. However, our understanding of the features and corresponding methods which can predict whether a specific sgRNA will effectively knockdown a transcript is very limited. Results Here we present a novel machine learning and computational tool, CASowary, to predict the efficacy of a sgRNA. We used publicly available RNA knockdown data from Cas13 characterization experiments for 555 sgRNAs targeting the transcriptome in HEK293 cells, in conjunction with transcriptome-wide protein occupancy information. Our model utilizes a Decision Tree architecture with a set of 112 sequence and target availability features, to classify sgRNA efficacy into one of four classes, based upon expected level of target transcript knockdown. After accounting for noise in the training data set, the noise-normalized accuracy exceeds 70%. Additionally, highly effective sgRNA predictions have been experimentally validated using an independent RNA targeting Cas system - CIRTS, confirming the robustness and reproducibility of our model's sgRNA predictions. Utilizing transcriptome wide protein occupancy map generated using POP-seq in HeLa cells against publicly available protein-RNA interaction map in Hek293 cells, we show that CASowary can predict high quality guides for numerous transcripts in a cell line specific manner. Conclusions Application of CASowary to whole transcriptomes should enable rapid deployment of CRISPR/Cas13 systems, facilitating the development of therapeutic interventions linked with aberrations in RNA regulatory processes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available